Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 1052976, 9 pages
https://doi.org/10.1155/2017/1052976
Research Article

Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study

1Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan
2School of Chinese Medicine, China Medical University, Taichung, Taiwan
3Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
4Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan
5Graduate Institute of Integrated Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan

Correspondence should be addressed to Sheng-Teng Huang; moc.oohay@gnet.gnehs

Received 24 June 2017; Accepted 12 September 2017; Published 30 October 2017

Academic Editor: Raffaele Capasso

Copyright © 2017 Kuo-Chin Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Zhang, X. Liu, J. Li, L. He, and D. Tripathy, “Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients,” Cochrane Database of Systematic Reviews, no. 2, article CD004921, 2007. View at Google Scholar · View at Scopus
  2. H. Greenlee, A. I. Neugut, L. Falci et al., “Association between complementary and alternative medicine use and breast cancer chemotherapy initiation the breast cancer quality of care (BQUAL) study,” JAMA Oncology, vol. 2, no. 9, pp. 1170–1176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-M. Li, Z.-H. Ye, J. Zhang et al., “Clinical trial with traditional Chinese medicine intervention "tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment" for chronic hepatitis B-associated liver failure,” World Journal of Gastroenterology, vol. 20, no. 48, pp. 18458–18465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. F. D. Jing, Z. G. Ma, Y. B. Liu et al., “Efficacy of traditional Chinese medicine for cooling blood and eliminating toxins and strengthening and purifying spleen in the treatment of refractory hepatitis C,” Journal of Biological Regulators and Homeostatic Agents, vol. 30, no. 1, pp. 247–253, 2016. View at Google Scholar
  5. F. H. Qi, Z. X. Wang, P. P. Cai et al., “Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection,” Drug Discoveries & Therapeutics, vol. 7, no. 6, pp. 212–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-W. Jane, M.-S. Lin, W.-N. Chiu, L.-J. Lai, P.-H. Chen, and M.-Y. Chen, “Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers,” BMC Public Health, vol. 16, no. 1, article 146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. V. A. J. Maria and R. M. M. Victorino, “Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis,” Hepatology, vol. 26, no. 3, pp. 664–669, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. B.-R. Wang, Y.-L. Chang, T.-J. Chen et al., “Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims,” Patient Preference and Adherence, vol. 8, pp. 671–682, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-L. Hsu, M.-H. Yen, P.-L. Kuo et al., “San-Zhong-Kui-Jian-Tang, a traditional Chinese medicine prescription, inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis,” Biological & Pharmaceutical Bulletin, vol. 29, no. 12, pp. 2388–2394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-H. Lin, K.-K. Chen, and J.-H. Chiu, “Coprescription of Chinese herbal medicine and Western medications among prostate cancer patients: a population-based study in Taiwan,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 147015, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Gu, I. Barone, L. Gelsomino et al., “Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation,” Journal of Cellular Physiology, vol. 227, no. 10, pp. 3363–3372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sigstedt, C. Hooten, M. Callewaert et al., “Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells,” International Journal of Oncology, vol. 32, no. 5, pp. 1085–1090, 2008. View at Publisher · View at Google Scholar
  13. J. Klawitter, J. Klawitter, J. Gurshtein et al., “Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study,” International Journal of Cancer, vol. 129, no. 12, pp. 2945–2957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-Y. Wang, D.-M. Wang, T. Y. Loo et al., “Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 751–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Wang, D. Wang, S. Han et al., “Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer,” PLoS ONE, vol. 8, no. 2, article e56631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Yang, J.-H. Ju, M. J. Jeon, X. Han, and I. Shin, “Danshen (Salvia miltiorrhiza) extract inhibits proliferation of breast cancer cells via modulation of akt activity and p27 level,” Phytotherapy Research, vol. 24, no. 2, pp. 198–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Wang, S. Li, Y. Fan et al., “Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 421–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Sato, K. Kita, C. Sato, and A. Kaneda, “Hochu-ekki-to (Bu-zhong-yi-qi-tang), a herbal medicine, enhances cisplatin-induced apoptosis in HeLa cells,” Molecular Medicine Reports, vol. 12, no. 4, pp. 6215–6220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Deng and H.-F. Chen, “Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines,” Journal of Chinese Integrative Medicine, vol. 7, no. 12, pp. 1174–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Chen, B. Ge, Y. Wang, Y. Ye, S. Zeng, and Z. Huang, “Biochanin a promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in breast cancer cells,” Cellular Physiology and Biochemistry, vol. 35, no. 2, pp. 639–646, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-S. Chen, Y. Liu, L.-Q. Lin et al., “Anti-proliferative effect of an extract of the root of Polygonum multiflorum Thunb. on MCF-7 human breast cancer cells and the possible mechanisms,” Molecular Medicine Reports, vol. 4, no. 6, pp. 1313–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-Y. Chen, Y.-H. Lin, and Y.-C. Chen, “Identifying chinese herbal medicine network for treating acne: implications from a nationwide database,” Journal of Ethnopharmacology, vol. 179, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. P. Chen, Y. Y. Kung, Y. C. Chen et al., “Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan,” Journal of Ethnopharmacology, vol. 117, no. 1, pp. 84–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-C. Chien, W.-C. Chang, P.-H. Lin et al., “A Chinese herbal medicine, Jia-Wei-Xiao-Yao-San, prevents dimethylnitrosamine-induced hepatic fibrosis in rats,” The Scientific World Journal, vol. 2014, Article ID 217525, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D.-S. Tsai, M.-H. Huang, Y.-S. Chang, T.-C. Li, and W.-H. Peng, “The use of Chinese herbal medicines associated with reduced mortality in chronic hepatitis B patients receiving lamivudine treatment,” Journal of Ethnopharmacology, vol. 174, article no. 9667, pp. 161–167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. G. T. Liu, “Pharmacological actions and clinical use of fructus schizandrae,” Chinese Medical Journal, vol. 102, no. 10, pp. 740–749, 1989. View at Google Scholar
  27. Y.-Y. Jia, R.-F. Guan, Y.-H. Wu et al., “Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells,” Molecular Medicine Reports, vol. 9, no. 4, pp. 1381–1387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Rehman, B. Ijaz, N. Fatima, S. A. Muhammad, and S. Riazuddin, “Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study,” Biomedicine & Pharmacotherapy, vol. 83, pp. 881–891, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. M.o.H.a.W. National Health Insurance Administration, Taiwan, R.O.C. National Health Insurance in Taiwan 2015-2016 Annual Report (bilingual) 2016.